WO2017134685A3 - Nouveaux composés hydrazino utilisés comme inhibiteurs de btk - Google Patents

Nouveaux composés hydrazino utilisés comme inhibiteurs de btk Download PDF

Info

Publication number
WO2017134685A3
WO2017134685A3 PCT/IN2017/050048 IN2017050048W WO2017134685A3 WO 2017134685 A3 WO2017134685 A3 WO 2017134685A3 IN 2017050048 W IN2017050048 W IN 2017050048W WO 2017134685 A3 WO2017134685 A3 WO 2017134685A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel
btk inhibitors
compounds
hydrazino compounds
hydrazino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2017/050048
Other languages
English (en)
Other versions
WO2017134685A2 (fr
Inventor
V.S.N. Murty KADIYALA
Virendra Narendra RAUT
Pratit SAVANT
Chetana Kaushal SHETH
Umesh Vishnu CHAUDHARI
Rajendrasinh Jashvantsinh RATHOD
Tushar Bhupendrabhai BHATT
Trinadha Rao Chitturi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharma Advanced Research Co Ltd
Original Assignee
Sun Pharma Advanced Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Research Co Ltd filed Critical Sun Pharma Advanced Research Co Ltd
Publication of WO2017134685A2 publication Critical patent/WO2017134685A2/fr
Publication of WO2017134685A3 publication Critical patent/WO2017134685A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouveaux composés hydrazino de Formule (I) utilisés comme inhibiteurs de tyrosine kinase de Bruton, leur procédé de préparation, et l'utilisation des composés dans la préparation de compositions pharmaceutiques pour le traitement thérapeutique de troubles impliquant une médiation de la tyrosine kinase de Bruton chez l'homme.
PCT/IN2017/050048 2016-02-02 2017-02-02 Nouveaux composés hydrazino utilisés comme inhibiteurs de btk Ceased WO2017134685A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621003737 2016-02-02
IN201621003737 2016-02-02

Publications (2)

Publication Number Publication Date
WO2017134685A2 WO2017134685A2 (fr) 2017-08-10
WO2017134685A3 true WO2017134685A3 (fr) 2018-06-28

Family

ID=59500779

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2017/050048 Ceased WO2017134685A2 (fr) 2016-02-02 2017-02-02 Nouveaux composés hydrazino utilisés comme inhibiteurs de btk

Country Status (1)

Country Link
WO (1) WO2017134685A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109111446B (zh) * 2017-06-22 2021-11-30 上海度德医药科技有限公司 一种具有药物活性的杂芳基化合物
US12109193B2 (en) 2018-07-31 2024-10-08 Loxo Oncology Inc. Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide
TWI762939B (zh) 2019-05-31 2022-05-01 大陸商海思科醫藥集團股份有限公司 Btk抑制劑環衍生物及其製備方法和藥學上的應用
CN111018865B (zh) * 2019-10-17 2021-01-15 山东大学 1-取代苄基吡唑并嘧啶衍生物及其制备方法与应用
TW202221002A (zh) * 2020-11-25 2022-06-01 大陸商四川海思科製藥有限公司 一種btk降解劑的製備方法
CN116323594A (zh) * 2020-11-25 2023-06-23 四川海思科制药有限公司 一种btk降解剂的制备方法
US12139492B2 (en) 2021-08-17 2024-11-12 Endotarget Inc. Substituted pyrimidines for the targeted degradation of Bruton's tyrosine kinase

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008039218A2 (fr) * 2006-09-22 2008-04-03 Pharmacyclics, Inc. Inhibiteurs de la tyrosine kinase de bruton
WO2013177668A1 (fr) * 2012-05-31 2013-12-05 Pharmascience, Inc. Inhibiteurs de protéine kinases
WO2014005217A1 (fr) * 2012-07-06 2014-01-09 Pharmascience Inc. Inhibiteurs de protéines kinases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008039218A2 (fr) * 2006-09-22 2008-04-03 Pharmacyclics, Inc. Inhibiteurs de la tyrosine kinase de bruton
WO2013177668A1 (fr) * 2012-05-31 2013-12-05 Pharmascience, Inc. Inhibiteurs de protéine kinases
WO2014005217A1 (fr) * 2012-07-06 2014-01-09 Pharmascience Inc. Inhibiteurs de protéines kinases

Also Published As

Publication number Publication date
WO2017134685A2 (fr) 2017-08-10

Similar Documents

Publication Publication Date Title
ZA202401324B (en) Tyrosine kinase inhibitors
PH12020500265A1 (en) Indole carboxamides compounds useful as kinase inhibitors
WO2015039612A8 (fr) Composé inhibiteur d'activités de kinase de btk et/ou de jak3
WO2017134685A3 (fr) Nouveaux composés hydrazino utilisés comme inhibiteurs de btk
MX2021004431A (es) Procesos novedosos.
MX2021007432A (es) Compuestos y composiciones para inhibir la actividad de shp2.
GEP20217248B (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
WO2016172134A3 (fr) Nouveaux composés
SA515360007B1 (ar) مركبات عطرية غير متجانسة كمثبطات بروتونز تيروسين كيناز ( btk)
WO2017205536A3 (fr) Composés thérapeutiques et leurs utilisations
WO2015101957A3 (fr) Nouveaux inhibiteurs de la glutaminase
NZ729603A (en) Heteroaryl compounds as btk inhibitors and uses thereof
WO2016109217A3 (fr) Inhibiteurs de la btk
MD4800B1 (ro) Compuşi de aminopirimidinil ca inhibitori de JAK
WO2015108490A3 (fr) Dérivés hétéroarylalcyne et leurs utilisations
EP4338802A3 (fr) Inhibiteurs de tyk2, utilisations et procédés de production associés
SA519401322B1 (ar) مركبات أريل كربوكساميد غير متجانسة كمثطبات لكيناز بروتين سيرين/ ثريونين متداخل مع المستقبل 2
EA201692260A1 (ru) Соединения 1,3,4-тиадиазола и их применение в лечении рака
WO2016102672A3 (fr) Composés pharmaceutiquement actifs
NZ702253A (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
EP4272832A3 (fr) Composés antimicrobiens, compositions et leurs utilisations
HK1252245A1 (zh) 用於治疗癌症的核苷酸
EA201990399A1 (ru) Соединения, композиции и их применение
WO2017168454A3 (fr) Nouveaux composés utilisés comme inhibiteurs de btk
MX2017014752A (es) Nuevos etinos de amidoheteroaril aroil hidrazida.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17747131

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17747131

Country of ref document: EP

Kind code of ref document: A2